Document is current
Any future updates will be listed below
-
Authors
Kashiwado, Yusuke
Kiyohara, Chikako
Kimoto, Yasutaka
Nagano, Shuji
Sawabe, Takuya
Oryoji, Kensuke
Mizuki, Shinichi
Nishizaka, Hiroaki
Yoshizawa, Seiji
Yoshizawa, Shigeru
Tsuru, Tomomi
Inoue, Yasushi
Ueda, Naoyasu
Ota, Shun-ichiro
Suenaga, Yasuo
Miyamura, Tomoya
Tada, Yoshifumi
Niiro, Hiroaki
Akashi, Koichi
Horiuchi, Takahiko https://orcid.org/0000-0002-1770-1087
- License Information
-
More Information
Article History
Received: 30 August 2021
Accepted: 21 May 2022
First Online: 1 June 2022
Declarations
:
: This study was approved by the ethics committee of Kyushu University Hospital (approval number 28- 255) in accordance with the Helsinki Declaration. The information regarding this study was announced on the hospital website and patients were given the opportunity to opt-out.
: Not applicable.
: TH has received research grant support from Mitsubishi-Tanabe Pharma, Chugai Pharma, Astellas Pharma, Bristol-Myers Squibb, Takeda Industrial Pharma, Eli Lilly and Company, CSL Behring KK, Asahi-Kasei Pharma, Santen Pharma, Teijin Pharma, and Daiichi-Sankyo. TM has received research grant support from Mitsubishi-Tanabe Pharma, Chugai Pharma, Pfizer, and AbbVie Pharma. YT received research grants and speaker’s fees from Chugai Pharmaceutical. HN has received research grant support from Astellas Pharma, Chugai Pharmaceutical, Daiichi-Sankyo, and Asahi-kasei Pharma. The other authors have no conflict of interest to disclose.
